Hospital’s volunteer army is on mission to swell ranks!
Addenbrooke’s Hospital – which like many other trusts said farewell to dedicated volunteers due to COVID-19 – has launched a major recruitment drive.
New genetic testing clinic for children with hearing loss
A new clinic at Cambridge University Hospitals NHS Foundation Trust is using genetic testing to help improve the treatment and care of children with hearing loss.
Construction and recruitment on track for new theatres
Three new operating theatres are on target to open this summer at Addenbrooke's Hospital to help ease waiting lists for routine orthopaedic operations – such as knee and hip replacements. Construction work on the site started last year and is progressing well, alongside a large recruitment drive for staff.
An Overview of China’s Biopharma Clusters
“Strength lies in differences, not similarities.”
- Stephen Covey
Biopharma: China Speed & China Scale
Recruiting and retaining older talent: 7 tips to make your business age-smart
If your business is struggling to find the right candidates for the right roles, perhaps it’s time to rethink what a ‘good’ candidate looks like. Perhaps it’s time to get ‘age-smart’.
Ubiquigent collaborates with University of Glasgow on translational structural biology to accelerate drug discovery within the (de)ubiquitylation field
Supporting Master’s student in Prof Helen Walden’s laboratory Project aims to determine USP30 structure to inform the design and discovery of novel inhibitorsDundee, UK - Ubiquigent Limited (Ubiquigent), a drug discovery and development compa
Surgeons’ operations are race against time
Addenbrooke’s Hospital performs 20,000 planned operations a year – and at 9pm on Wednesday (25 Jan) BBC Two viewers will have the opportunity to see two of the most technically demanding.
Final days to enter Cambridge Independent Science and Technology Awards 2023
There are just days left to get your entry in to the Cambridge Independent Science and Technology Awards 2023. Enter free online by 11pm on January 27
New Year, new you, new offer from The Jockey Club
For every NEW conference booked and confirmed to take place from 5th January to 31st March 2023, you can take your pick from a variety of options to add to your Day Delegate package from Danish pastries to fresh fruit platters and add them to your event, completely free of charge! We can offer your delegates an abundance of space, access to outdoor areas and spacious private breakout lounges,…
Cresset January 2023 Newsletter
After a busy start to 2023, our January monthly update newsletter includes features around Flare Visualizer, Virtual Screening, Molecular Dynamics, and more!
University of Exeter enters virtual screening collaboration with Cresset Discovery to accelerate discovery of novel antimicrobial drugs
Cresset Discovery, provider of molecular modeling expertise for drug discovery, is collaborating with the University of Exeter to find new antimicrobial drugs.
The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced that the U.S.
TTP introduces Cellular Origins, a TTP Company focussed on delivering scalable manufacture of cell and gene therapies
TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a TTP Company. Cellular Origins is a TTP spin-out, created to enable scalable, cost-effective and efficient manufacture of cell and gene therapies.
Avacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Study
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces that AVA6000 continues to show a very favourable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase 1 clinical trial.
CUH neurosurgeon wins prestigious Hunterian Professorship award
A consultant neurosurgeon from Addenbrooke’s Hospital has been given a prestigious award for his cutting-edge research into traumatic brain injury.
Tom’s Trust spread Christmas cheer to children in hospital
From superhero capes to books and cuddly soft toys, children were treated to some wonderful gifts from Tom’s Trust while spending time in hospital over the Christmas period.
The year in review: Updates and trends
In 2022, everyone witnessed intense activity in matters related to supply chain issues, the energy transition, oil & gas, post-M&A disputes, licensing issues, breaches of distribution contracts and increasingly arbitrations deriving from geopolitical issues in Europe and Asia and from com
Arecor announces transfer of AT307 to Hikma
License milestone to develop and commercialise ready-to-use medicine achieved. Arecor regains rights to AT282 following portfolio review at Hikma.
Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease
Preclinical program with potential for disease modifying therapeutic
FUJIFILM Irvine Scientific Launches HEK293 Feed, Specifically Designed for Viral Vector Production
Chemically defined, BalanCD HEK293 Viral Feed enhances viral vector production for gene therapy applications and viral vector-based vaccines
Local Employee Benefit Consultancy EBCam Ltd launches their 2023 survey to help companies benchmark their reward offering.
Specialist Employee Benefit consultancy EBcam Ltd, who are based out of Cambridge and Bury St Edmunds have re-launched their own employee benefit survey for 2023. The survey is free for local companies to participate in.
Vector BioPharma and iBET collaborate to develop high-throughput analytical methods and scalable processes for gene delivery
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that it has entered into a strategic, multi-phase collaboration with the Instituto de Biologia Experim
2023: a new year with a renewed focus for the Guardtech Group
Cleanroom construction specialists’ multi-faceted approach set to reach new levels and new audiences in 2023.
Astrea Bioseparations acquires Delta Precision Ltd, a leading manufacturer of chromatography columns for biomanufacturing
Cambridge, UK - Astrea Bioseparations, a leading provider of high-quality bioseparation and purification technologies, announced today the acquisition of Delta Precision Ltd.
Ubiquigent appoints Dr Xavier Jacq to Scientific Advisory Board
Leading expert in DUB biology and drug discovery further strengthens Ubiquigent’s DUB-focused capabilities and internal pipelineDundee, UK - Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB)